Precigen (PGEN) Research & Development (2012 - 2026)

Precigen (PGEN) has 15 years of Research & Development data on file, last reported at $5.6 million in Q1 2026.

• On a quarterly basis, Research & Development fell 46.19% year-over-year to $5.6 million in Q1 2026; TTM through Mar 2026 was $36.5 million, a 25.98% decrease from a year earlier, with the FY2025 full-year figure at $41.3 million, down 22.12% from the prior year.
• Research & Development for Q1 2026 stood at $5.6 million, down from $7.0 million in the prior quarter.
• Over the last five years, Research & Development for PGEN reached as high as $15.7 million in Q2 2024 and fell as low as $5.6 million in Q1 2026.
• Historically, Research & Development has averaged $11.5 million across 5 years, with a median of $11.8 million in 2022.
• Across the five-year window, Research & Development soared 32.16% in 2024 and slumped 46.19% in 2026, its largest moves.
• Year by year, Research & Development stood at $10.8 million in 2022, then climbed by 20.39% to $13.0 million in 2023, then slipped by 9.51% to $11.8 million in 2024, then plunged by 40.55% to $7.0 million in 2025, then fell by 19.34% to $5.6 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $5.6 million in Q1 2026, $7.0 million in Q4 2025, and $12.4 million in Q3 2025.